Product Information
LUBIPROSTONE 8 MCG CAPSULE is a generic product labeled by Par Health USA, LLC, priced at $0.6039 per EA under NDC 00254302802. Its NADAC has been published 271 times since Apr 21, 2021.
Strength
8 ug/1
Manufacturer
Par Health USA, LLCNDC
00254302802
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LUBIPROSTONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021908On Market Since
1/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 8 MCG CAPSULE has been published 271 times since Apr 21, 2021, and over the history we have for it it has declined 87.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6039 per EA |
|---|---|
| All-time high | $4.8390 (Mar 16, 2022) |
| All-time low | $0.5447 (Nov 20, 2024) |
| 52-week high | $0.8921 |
| 52-week low | $0.6039 |
| Median price | $1.5890 |
| Average price | $2.3409 |
| Largest weekly change | -46.8% (Dec 20, 2023) |
| Weeks tracked | 271 |
| Tracking since | Apr 21, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 8 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 8 MCG CAPSULE, manufactured by Par Health USA, LLC, is $0.6039 per EA (NDC 00254302802), effective Jun 24, 2026.
How has the price of LUBIPROSTONE 8 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has declined 87.3%. It has been tracked across 271 weekly CMS publications since Apr 21, 2021.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 8 MCG CAPSULE?
Since Apr 21, 2021, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has ranged from a low of $0.5447 (Nov 20, 2024) to a high of $4.8390 (Mar 16, 2022), with a median of $1.5890 per EA.
Are there cheaper alternatives to LUBIPROSTONE 8 MCG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LUBIPROSTONE 8 MCG CAPSULE, but none are currently priced below it.
Who manufactures LUBIPROSTONE 8 MCG CAPSULE?
LUBIPROSTONE 8 MCG CAPSULE (NDC 00254302802) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification